J M Quinn

Summary

Affiliation: University of Melbourne
Country: Australia

Publications

  1. ncbi A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro
    J M Quinn
    The University of Melbourne, Department of Medicine and St Vincent s Institute of Medical Research, Fitzroy, Australia
    Endocrinology 139:4424-7. 1998
  2. ncbi The generation of highly enriched osteoclast-lineage cell populations
    J M W Quinn
    St Vincent s Institute of Medical Research, Fitzroy, Victoria, Australia
    Bone 30:164-70. 2002
  3. ncbi A novel osteoblast-derived C-type lectin that inhibits osteoclast formation
    H Zhou
    Department of Medicine, University of Melbourne, St Vincent s Hospital, and St Vincent s Institute of Medical Research, Fitzroy, Victoria 3065, Australia
    J Biol Chem 276:14916-23. 2001
  4. ncbi Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions
    J M Quinn
    Department of Medicine, St. Vincent's Institute of Medical Research and The University of Melbourne, Fitzroy, Victoria, Australia
    J Bone Miner Res 16:1787-94. 2001
  5. ncbi Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues
    V Kartsogiannis
    Department of Medicine, The University of Melbourne and St Vincent s Institute of Medical Research, St Vincent s Hospital, Fitzroy, Victoria, Australia
    Bone 25:525-34. 1999
  6. ncbi Myeloma cells can directly contribute to the pool of RANKL in bone bypassing the classic stromal and osteoblast pathway of osteoclast stimulation
    F P L Lai
    Alfred Pathology Service, Alfred Hospital, Melbourne, Victoria, Australia
    Br J Haematol 126:192-201. 2004

Collaborators

Detail Information

Publications6

  1. ncbi A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro
    J M Quinn
    The University of Melbourne, Department of Medicine and St Vincent s Institute of Medical Research, Fitzroy, Australia
    Endocrinology 139:4424-7. 1998
    ..We propose that this methodology can be employed to investigate the direct effects of cytokines and other factors on human osteoclast differentiation...
  2. ncbi The generation of highly enriched osteoclast-lineage cell populations
    J M W Quinn
    St Vincent s Institute of Medical Research, Fitzroy, Victoria, Australia
    Bone 30:164-70. 2002
    ..These can be employed to generate osteoclast populations of high purity and in large numbers when stimulated by TGFbeta, which greatly augments the osteoclastogenic effects of RANKL...
  3. ncbi A novel osteoblast-derived C-type lectin that inhibits osteoclast formation
    H Zhou
    Department of Medicine, University of Melbourne, St Vincent s Hospital, and St Vincent s Institute of Medical Research, Fitzroy, Victoria 3065, Australia
    J Biol Chem 276:14916-23. 2001
    ..The overlapping tissue distribution of OCIL mRNA and protein with that of RANKL strongly suggests an interaction between these molecules in the skeleton and in extraskeletal tissues...
  4. ncbi Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions
    J M Quinn
    Department of Medicine, St. Vincent's Institute of Medical Research and The University of Melbourne, Fitzroy, Victoria, Australia
    J Bone Miner Res 16:1787-94. 2001
    ..Such actions may be critical to the control of physiological and pathophysiological osteolysis...
  5. ncbi Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues
    V Kartsogiannis
    Department of Medicine, The University of Melbourne and St Vincent s Institute of Medical Research, St Vincent s Hospital, Fitzroy, Victoria, Australia
    Bone 25:525-34. 1999
    ..RANKL was also developmentally regulated, as evidenced by its expression in the intestine, liver, and lung at E15 and newborn mouse but not in the adult...
  6. ncbi Myeloma cells can directly contribute to the pool of RANKL in bone bypassing the classic stromal and osteoblast pathway of osteoclast stimulation
    F P L Lai
    Alfred Pathology Service, Alfred Hospital, Melbourne, Victoria, Australia
    Br J Haematol 126:192-201. 2004
    ..Finally, we provide evidence that the differentiation observed is at least in part the result of myeloma cell expression of RANKL. We therefore conclude that myeloma cells can directly contribute to the pool of RANKL in bone...